Publications

Found 4 results
Filters: Keyword is Male and Author is Lahoutte, Tony  [Clear All Filters]
2014
Zheng, F., S. Put, L. Bouwens, T. Lahoutte, P. Matthys, S. Muyldermans, P. De Baetselier, N. Devoogdt, G. Raes, and S. Schoonooghe, "Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis.", J Nucl Med, vol. 55, issue 5, pp. 824-9, 2014 May.
2012
D'huyvetter, M., A. Aerts, C. Xavier, I. Vaneycken, N. Devoogdt, M. Gijs, N. Impens, S. Baatout, B. Ponsard, S. Muyldermans, et al., "Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.", Contrast Media Mol Imaging, vol. 7, issue 2, pp. 254-64, 2012 Mar-Apr.
Hmila, I., B. Cosyns, H. Tounsi, B. Roosens, V. Caveliers, R. Ben Abderrazek, S. Boubaker, S. Muyldermans, M. El Ayeb, B. Bouhaouala-Zahar, et al., "Pre-clinical studies of toxin-specific nanobodies: evidence of in vivo efficacy to prevent fatal disturbances provoked by scorpion envenoming.", Toxicol Appl Pharmacol, vol. 264, issue 2, pp. 222-31, 2012 Oct 15.
2011
Gainkam, L. Olive Tcho, M. Keyaerts, V. Caveliers, N. Devoogdt, C. Vanhove, L. Van Grunsven, S. Muyldermans, and T. Lahoutte, "Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy.", Mol Imaging Biol, vol. 13, issue 5, pp. 940-8, 2011 Oct.